
Overview
Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999.
Dr. Manabe is rated as an Experienced provider by MediFind in the treatment of Kaposi Sarcoma. Her top areas of expertise are HIV/AIDS, Cryptococcosis, Gonorrhea, Meningitis, and Tissue Biopsy.
Her clinical research consists of co-authoring 318 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Kaposi Sarcoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
1800 Orleans Street, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Eric Engels is an Infectious Disease provider in Baltimore, Maryland. Dr. Engels is rated as an Advanced provider by MediFind in the treatment of Kaposi Sarcoma. His top areas of expertise are Kaposi Sarcoma, HIV/AIDS, Hepatitis, and Mononucleosis.
Irini Sereti is an Infectious Disease provider in Bethesda, Maryland. Dr. Sereti is rated as a Distinguished provider by MediFind in the treatment of Kaposi Sarcoma. Her top areas of expertise are HIV/AIDS, Kaposi Sarcoma, Sepsis, Mycobacterium Avium Complex Infections, and Colonoscopy.
The Johns Hopkins Hospital
Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is rated as a Distinguished provider by MediFind in the treatment of Kaposi Sarcoma. His top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, and Hepatitis B.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- HIV/AIDSDr. Manabe isElite. Learn about HIV/AIDS.
- Distinguished
- CryptococcosisDr. Manabe isDistinguished. Learn about Cryptococcosis.
- GonorrheaDr. Manabe isDistinguished. Learn about Gonorrhea.
- MeningitisDr. Manabe isDistinguished. Learn about Meningitis.
- Severe Acute Respiratory Syndrome (SARS)Dr. Manabe isDistinguished. Learn about Severe Acute Respiratory Syndrome (SARS).
- SyphilisDr. Manabe isDistinguished. Learn about Syphilis.
- Advanced
- AIDS Dementia ComplexDr. Manabe isAdvanced. Learn about AIDS Dementia Complex.
- AIDS Dysmorphic SyndromeDr. Manabe isAdvanced. Learn about AIDS Dysmorphic Syndrome.
- ChlamydiaDr. Manabe isAdvanced. Learn about Chlamydia.
- COVID-19Dr. Manabe isAdvanced. Learn about COVID-19.
- Long Haul COVIDDr. Manabe isAdvanced. Learn about Long Haul COVID.
- MyelitisDr. Manabe isAdvanced. Learn about Myelitis.
- Experienced
- Bacterial MeningitisDr. Manabe isExperienced. Learn about Bacterial Meningitis.
- ChikungunyaDr. Manabe isExperienced. Learn about Chikungunya.
- Dengue FeverDr. Manabe isExperienced. Learn about Dengue Fever.
- Genital HerpesDr. Manabe isExperienced. Learn about Genital Herpes.
- HepatitisDr. Manabe isExperienced. Learn about Hepatitis.
- Hepatitis CDr. Manabe isExperienced. Learn about Hepatitis C.
